Use of probiotics in prevention and treatment of patients with Clostridium difficile infection

JE Ollech, NT Shen, CV Crawford, Y Ringel - Best Practice & Research …, 2016 - Elsevier
Clostridium difficile is an anaerobic, gram positive, sporulating, toxin-producing bacillus
which causes a spectrum of clinical disease ranging from an asymptomatic carrier state to …
被引用次数：34 相关文章

Use of probiotics in prevention and treatment of patients with Clostridium difficile infection

JE Ollech, NT Shen, CV Crawford, Y Ringel - Best Practice & Research …, 2016 - infona.pl
Clostridium difficile is an anaerobic, gram positive, sporulating, toxin-producing bacillus
which causes a spectrum of clinical disease ranging from an asymptomatic carrier state to …

Use of probiotics in prevention and treatment of patients with Clostridium difficile infection.

JE Ollech, NT Shen, CV Crawford… - Best Practice & research …, 2016 - europepmc.org
Clostridium difficile is an anaerobic, gram positive, sporulating, toxin-producing bacillus
which causes a spectrum of clinical disease ranging from an asymptomatic carrier state to …

Use of probiotics in prevention and treatment of patients with Clostridium difficile infection.

JE Ollech, NT Shen, CV Crawford, Y Ringel - 2016 - cabidigitallibrary.org
Clostridium difficile is an anaerobic, gram positive, sporulating, toxin-producing bacillus
which causes a spectrum of clinical disease ranging from an asymptomatic carrier state to …

Use of probiotics in prevention and treatment of patients with Clostridium difficile infection

JE Ollech, NT Shen, CV Crawford… - Best practice & …, 2016 - pubmed.ncbi.nlm.nih.gov
Clostridium difficile is an anaerobic, gram positive, sporulating, toxin-producing bacillus
which causes a spectrum of clinical disease ranging from an asymptomatic carrier state to …

[引用][C] Use of probiotics in prevention and treatment of patients with Clostridium difficile infection

JE Ollech, NT Shen, CV Crawford… - Best Practice & …, 2016 - Elsevier Limited